Merck & Co.’s Clesrovimab Could Rival Sanofi/AZ’s Beyfortus In RSV

 
• By Jessica Merrill
  
RSV
Merck released positive data on a monoclonal antibody to protect against RSV • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D